ProPhase Labs, Inc. — Form D
ProPhase Labs, Inc. of UNIONDALE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-05. The offering totals $6.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-08-05
- Form: D
- Accession: 0001641172-25-022239
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $3.0M
- Remaining: $3.0M
- Minimum investment: $500K
- Investors: 2
- Date of first sale: 2025-07-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-553763
Issuer
- Name: ProPhase Labs, Inc.
- CIK: 0000868278
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 626 RXR PLAZA, 6TH FLOOR, UNIONDALE, NY, 11556
- Phone: 215-345-0919
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| CAROLINA ABENANTE | Director | UNIONDALE, NY |
| LOUIS GECKEL | Director | UNIONDALE, NY |
| WARREN HIRSCH | Director | UNIONDALE, NY |
| TED KARKUS | Director | UNIONDALE, NY |
| TED KARKUS | Executive Officer | UNIONDALE, NY |
| Louis V Gleckel | Director | Doylestown, PA |
| Robert V Cuddihy, Jr. | Executive Officer | Doylestown, PA |
| James V McCubbin | Director | Doylestown, PA |
| Mark V Burnett | Director | Doylestown, PA |
| Jason V Barr | Director | Doylestown, PA |
| Mark V Leventhal | Director | Doylestown, PA |
| John V DeShazo | Director | Doylestown, PA |
| Mark V Frank | Director | Doylestown, PA |
Other filings by this issuer (3)
More